Diagnosis and treatment of rhabdomyosarcomas
M Łomiak, T Świtaj, M Spałek… - Oncology in Clinical …, 2023 - journals.viamedica.pl
Rhabdomyosarcoma (RMS) is a soft tissue sarcoma. The primary tumor is most commonly
localized in the head and neck, the urogenital system, or the limbs. Classification by the …
localized in the head and neck, the urogenital system, or the limbs. Classification by the …
[PDF][PDF] A systematic review of early phase studies for children and young people with relapsed and refractory rhabdomyosarcoma: the REFoRMS-SR project. CCLG
L Beresford, C Evans, G Bryan, H Fulbright, S Crowther… - cclg.org.uk
Rhabdomyosarcoma is a form of cancer that most commonly affects children and young
people. About one third of children and young people with rhabdomyosarcoma have …
people. About one third of children and young people with rhabdomyosarcoma have …
[HTML][HTML] Systemic chemotherapy of advanced soft tissue sarcomas
M Besiroglu, F Dane, A Ciltas, M Benekli - Journal of Oncological Sciences, 2017 - Elsevier
Soft tissue sarcomas, which originate from the mesenchymal tissue, represent a rare
disease group with more than 100 subtypes. Primary treatment is surgical excision. In locally …
disease group with more than 100 subtypes. Primary treatment is surgical excision. In locally …
[PDF][PDF] Update on new diagnostic and therapeutic approaches for sarcomas
P Dileo, GD Demetri - Clinical Advances in Hematology and …, 2005 - researchgate.net
Sarcomas represent a family of uncommon malignancies related by histopathology and
developmental biology. Sarcomas arise from any of the mesodermal tissues anywhere in the …
developmental biology. Sarcomas arise from any of the mesodermal tissues anywhere in the …
A Thermosensitive Liposome Formulation of Vinorelbine for the Treatment of Recurrent Rhabdomyosarcoma
ML Regenold - 2023 - search.proquest.com
Approximately one third of rhabdomyosarcoma (RMS) patients experience disease
recurrence and subsequently face a dismal prognosis. In most cases, the disease …
recurrence and subsequently face a dismal prognosis. In most cases, the disease …
Diffuse intrinsic brainstem tumor in an infant: a case of therapeutic efficacy with vinorelbine
AM Cappellano, E Bouffet, S Cavalheiro… - Journal of Pediatric …, 2011 - journals.lww.com
Abstract Brainstem gliomas constitute 10% to 20% of all pediatric tumors of the central
nervous system, and diffusely infiltrative brainstem gliomas are the most common brainstem …
nervous system, and diffusely infiltrative brainstem gliomas are the most common brainstem …
RETRACTED ARTICLE: New drug developments for patients with metastatic soft tissue sarcoma
JT Hartmann, S Patel - Current oncology reports, 2005 - Springer
For the subgroup of patients with inoperable gastrointestinal stromal tumors, progress has
been made by the rapid development and approval of the targeted therapy imatinib …
been made by the rapid development and approval of the targeted therapy imatinib …
Optimised three-dimensional in vitro retinoblastoma models tailored for drug discovery and clinical translatability
I Sinenko - 2023 - infoscience.epfl.ch
Retinoblastoma, while relatively rare, stands as the most prevalent intraocular cancer. In
Switzerland, the survival rate approaches 100%, but it drops to less than 50% in low-income …
Switzerland, the survival rate approaches 100%, but it drops to less than 50% in low-income …
VIVA (vinorelbine, ifosfamide, vincristine, actinomycin‐D): A new regimen in the armamentarium of systemic therapy for high‐risk rhabdomyosarcoma
A Ferrari, S Chiaravalli, M Zecca… - Pediatric Blood & …, 2020 - Wiley Online Library
The study reports the treatment feasibility, and secondly efficacy, of a novel chemotherapy
regimen, which adds vinorelbine to the ifosfamide‐vincristine‐actinomycin‐D combination …
regimen, which adds vinorelbine to the ifosfamide‐vincristine‐actinomycin‐D combination …